(Press-News.org) Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.
The study questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults. Pfizer’s 2022 clinical trial found reduced COVID-19 hospitalization in unvaccinated middle-aged adults; while a subsequent 2024 clinical trial found no significant reduction in vaccinated middle-aged adults. Since most older Americans have already received two or more COVID-19 vaccines, Paxlovid’s effectiveness on vaccinated older adults has remained an important unanswered question.
“Since the strongest predictor of severe COVID-19 is advanced age, it has been crucial to obtain evidence on whether the results of the Pfizer trials generalized to older and vaccinated populations,” said Dr. John Mafi, an associate professor-in-residence of medicine in the division of general internal medicine and health services research at the David Geffen School of Medicine at UCLA and the study’s lead author.
“Our study effectively rules out the notion that Paxlovid causes large reductions in COVID-19 hospitalization in vaccinated older adults,” Mafi said. “While we cannot rule out a small reduction in COVID-19 hospitalization, our results indicate that at best, Paxlovid’s potential effect on COVID-19 hospitalization among vaccinated older adults is four times weaker than the effect originally reported in Pfizer’s 2022 clinical trial.”
The findings, to be published in the peer-reviewed JAMA, “are important because Pfizer’s 2022 clinical trial continues to serve as the foundation of evidence supporting Paxlovid’s perceived effectiveness, list price of about $1,650 per treatment course, and widespread global use,” Mafi said.
“Since the study found no significant effect on COVID-19 hospitalizations and deaths among vaccinated older adults, our findings underscore the urgent need for further randomized-clinical trials investigating Paxlovid’s effects in higher-risk populations, such as older subgroups who are frail or immunosuppressed,” said Dr. Katherine Kahn, distinguished professor of medicine in the general internal medicine division and the study’s senior author.
To determine the association between Paxlovid and COVID-19-related hospitalizations, all-cause hospitalizations and all-cause mortality outcomes, the researchers exploited a natural experiment in Ontario, Canada. Between April 1 and November 30, 2022, Ontario implemented an age-restrictive policy on access to Paxlovid—reserving it for symptomatic, COVID-19-positive adults aged 70 years and older, unless they were immunocompromised or had other risk factors. The researchers used data from several Ontario health databases linked by ICES, the major steward of Ontario health data.
They compared outcomes of patients who were just below vs just above 70-years-old who were plausibly similar except for their exposure to Paxlovid. The researchers found that among 1.6 million highly vaccinated older Ontarians, the policy to restrict Paxlovid to those aged 70, increased the rate of Paxlovid prescriptions by 118% at age 70. This doubling in the prescription rate did not, however, translate into improved COVID-19-related hospitalization, all-cause hospitalization, or all-cause mortality outcomes.
By restricting Paxlovid access by age, the policy created a rare natural experiment that the study analyzed to evaluate Paxlovid’s impact on key health outcomes, effectively avoiding the common observational research pitfall known as unobserved confounding. “Unobserved confounding is a problem because the decision to use Paxlovid is not random, and the factors that influence its use are able to influence the risk of hospitalization or mortality,” said study co-author Sitaram Vangala, biostatistician in the Department of Medicine Statistics Core.
“Because access to Paxlovid in this study was in effect randomized for those close to the age 70 cutoff, our results are unlikely to reflect unobserved confounding,” Vangala said. “This may explain why our results align with the recent negative 2024 clinical trial among vaccinated middle-aged adults, but not with observational studies showing that Paxlovid is associated with large reductions in hospitalization and mortality in vaccinated older adults.”
The study is limited by a lack of individual patient-level data regarding symptoms, timing of previous COVID-19 vaccinations, receipt of Paxlovid, and medication adherence.
Additional co-authors Manying Cui and Artem Romanov of UCLA, and Dr. Moira Kapral and Dr. Peter Wu of the University of Toronto. Dr. Wu is affiliated with ICES.
The study was funded by the Commonwealth Fund and a National Institute on Aging Beeson Emerging Leaders in Aging Research Career Development Award (K76AG064392-01A1). This study was also supported by ICES, which is supported by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC).
END
Paxlovid’s impact on hospitalization and death in COVID-vaccinated older adults far weaker than previously thought
2025-02-20
ELSE PRESS RELEASES FROM THIS DATE:
Additive manufacturing of biomedical metals for medical implant fabrication
2025-02-20
Biomedical metal implant materials are widely used in clinical applications, including dental implants, hip replacement, bone plates, and screws. However, traditional manufacturing processes face limitations in meeting customized medical needs, internal structural control, and efficient material utilization. For example, when producing complex-shaped titanium alloy parts using conventional methods, the material consumption ratio is as high as 10:1-20:1, leading to significant material waste.
As a result, ...
Antioxidant-enzyme Interaction in non-communicable diseases
2025-02-20
Introduction
Oxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role in the development of non-communicable diseases (NCDs). These diseases, including cardiovascular disorders, diabetes, neurodegenerative conditions, cancer, and liver and kidney diseases, are among the leading causes of morbidity and mortality worldwide. Enzymatic and non-enzymatic antioxidants serve as the body’s primary defense against ROS, maintaining redox homeostasis and preventing cellular damage. However, when ROS levels exceed the capacity of antioxidant defenses, oxidative stress ensues, contributing ...
Turtles change nesting patterns in response to climate change
2025-02-20
New research shows that turtles are responding to climate change by nesting earlier.
Researchers monitoring nesting green and loggerhead turtles in Cyprus have discovered they are returning to their regular nesting spots earlier each year to compensate for rising temperatures.
In sea turtles, temperature determines the biological sex of offspring, with more females born when it is warmer, as well as fewer successful hatchings when it gets too hot.
Turtles also have “natal philopatry”, which means they return to nest in the area where they themselves hatched.
A research team from the University of Exeter and the Society for the Protection of ...
New research links grape consumption to improved muscle health in both men and women
2025-02-20
A new study from Western New England University (WNE) has revealed that long-term grape consumption significantly impacts muscle health, with notable benefits for both men and women. The research, published in the journal Foods, suggests that a diet including grapes can modify gene expression in muscle, potentially offering a new nutritional strategy for maintaining muscle mass and function.
Around 30 million tons of grapes are consumed every year, and their benefits extend beyond nutrition. Grapes have been shown to ...
Both sides of the coin: Lack of consensus on continuing vs. discontinuing opioid medications prescriptions for adults with chronic pain
2025-02-20
INDIANAPOLIS – Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help some patients.
With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain. The authors analyzed the opinions of 28 experts on the harms versus benefits of maintaining, tapering or terminating opioid pain medication prescriptions ...
National Academy of Inventors welcomes 162 emerging inventors
2025-02-20
The National Academy of Inventors (NAI) has announced the 2025 class of Senior Members, comprised of 162 emerging inventors from NAI’s Member Institutions. This year’s class of NAI Senior Members is the largest to date and hails from 64 NAI Member Institutions across the nation. Collectively, they are named inventors on over 1200 U.S. patents.
“To see this program grow year over year is a testament to the dedication our Member Institutions have to fostering innovation on their campuses and supporting their inventive staff ...
Narcissists more likely to feel ostracized
2025-02-20
Narcissists feel ostracized more frequently than their less self-absorbed peers, according to research published by the American Psychological Association. This may stem not only from being shunned due to their personalities but from a tendency to misinterpret ambiguous social signals as exclusion.
“Feeling ostracized is a subjective experience based on the perception of social cues by the individual. Some may be intentionally ostracized, while others may merely believe they are being excluded when that’s not the case,” said lead author Christiane Büttner, PhD, of the University of Basel. “Our findings suggest that ...
Unfolded protein response: A key regulator of intestinal health and disease
2025-02-20
The intestinal epithelium is a highly dynamic barrier that regulates digestion, absorption, immune responses, and communication between the gut microbiota and the nervous system. To maintain homeostasis, intestinal epithelial cells (IECs) must efficiently manage protein production and secretion, a process tightly controlled by the unfolded protein response (UPR).
New research published in eGastroenterology demonstrates that disruptions in the UPR contribute to inflammatory bowel diseases (IBD), colorectal cancer, and other gut-related disorders. This highlights potential therapeutic strategies to restore ...
Small amounts of moderate to vigorous physical activity are associated with big reductions in dementia risk
2025-02-20
A little movement could help prevent dementia, even for frail older adults, suggests a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
The researchers found that engaging in as little as 35 minutes of moderate to vigorous physical activity per week, compared to zero minutes per week, was associated with a 41% lower risk of developing dementia over an average four-year follow-up period. Even for frail older adults—those at elevated risk of adverse health outcomes—greater activity was associated with lower dementia risks.
The ...
Enhancing adhesive performance of polyvinyl alcohol with sub-nanoscale polyoxotungstate clusters under extreme conditions
2025-02-20
Water-based adhesives face several challenges despite their environmental benefits. One major issue is that achieving high adhesion strength on various substrates, especially in wet or humid conditions, is difficult due to the inherent properties of water-based systems. Additionally, the volatility of water also leads to issues like bubble formation and uneven drying, affecting the adhesive's performance and appearance. Moreover, formulating water-based adhesives with both high solids content and low viscosity is technically demanding, ...